Feasibility Study of a New Immunoglobulin E (IgE) Assay Method
Recruiting
Observational Study
Allergy and Immunology
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 6 Months – 99
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,376 (estimated)
- Sponsor
- University Hospital, Toulouse · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Males or females 6 months' old or older
* Sensitization or allergy towards a trophallergen, an aeroallergen, hymenoptera venom or drug proven by:
* positive skin test (s)
* and / or IgE specific (s)\> 0.1 kUA / L
* and / or anamnesis in favor of an allergic reaction of …
Contacts